Daniel C Gibbons

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 20

Top Venues

BMC infectious diseases

Clinical drug investigation

Acta clinica Belgica

Current medical research and opinion

GlaxoSmithKline Plc

Imperial College London (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

GlaxoSmithKline Plc Jan 20 2017

United Kingdom

Manager, Respiratory Epidemiology :: Real World Evidence & Epidemiology

Imperial College London Jun 02 2015

United Kingdom

Honorary Clinical Research Fellow :: Primary Care & Population Health

Education History

Imperial College London Oct 01 2011 - Jun 16 2015

United Kingdom

PHD :: Primary Care & Public Health

University College London Sep 30 1998 - Jun 30 2005

United Kingdom

BSC :: Medical School

Publications

Myriam Drysdale, Holly Tibble, Vishal Patel, Daniel C Gibbons, Emily J Lloyd, William Kerr, Calum Macdonald, Helen J Birch, Aziz Sheikh
Characteristics and outcomes of patients with COVID-19 at high risk of disease progression receiving sotrovimab, oral antivirals, or no treatment: a retrospective cohort study. BMC infectious diseases 24 (1) (2024)
Christopher F Bell, Priyanka Jain, Raj Desai, Daniel C Gibbons, Myriam Drysdale, Maral DerSarkissian, Vishal Patel, Helen J Birch, Emily J Lloyd, Adina Zhang, Mei Sheng Duh, null null
Real-World Effectiveness of Sotrovimab for the Early Treatment of COVID-19: Evidence from the US National COVID Cohort Collaborative (N3C). Clinical drug investigation 44 (3) (2024)
Myriam Drysdale, Thor Hautekiet, Moushmi Singh, Joris Hautekiet, Linda Ludikhuyze, Vishal Patel, Daniel C Gibbons, Dorothée De Roeck, Kirsten Colpaert, Emily J Lloyd, Eva Van Braeckel
Characteristics and outcomes of patients treated with sotrovimab to prevent progression to severe COVID-19 in Belgium. Acta clinica Belgica (2024)
Christopher F Bell, Priyanka Jain, Raj Desai, Daniel C Gibbons, Myriam Drysdale, Maral DerSarkissian, Vishal Patel, Helen J Birch, Emily J Lloyd, Adina Zhang, Mei Sheng Duh, null null
Real-World Effectiveness of Sotrovimab for the Early Treatment of COVID-19: Evidence from the US National COVID Cohort Collaborative (N3C). Clinical drug investigation (2024)
Vishal Patel, Marcus J Yarwood, Bethany Levick, Daniel C Gibbons, Myriam Drysdale, William Kerr, Jonathan D Watkins, Sophie Young, Benjamin F Pierce, Emily J Lloyd, Helen J Birch, Tahereh Kamalati, Stephen James Brett
Characteristics and outcomes of patients with COVID-19 at high risk of disease progression receiving sotrovimab, oral antivirals or no treatment in England: a retrospective cohort study. Current medical research and opinion 40 (8) (2024)
Christopher F Bell, Priyanka Jain, Raj Desai, Daniel C Gibbons, Myriam Drysdale, Maral DerSarkissian, Vishal Patel, Helen J Birch, Emily J Lloyd, Adina Zhang, Mei Sheng Duh, null null
Real-World Effectiveness of Sotrovimab for the Early Treatment of COVID-19: Evidence from the US National COVID Cohort Collaborative (N3C). Clinical drug investigation 44 (3) (2024)
Christopher F Bell, Priyanka Jain, Raj Desai, Daniel C Gibbons, Myriam Drysdale, Maral DerSarkissian, Vishal Patel, Helen J Birch, Emily J Lloyd, Adina Zhang, Mei Sheng Duh, null null
Real-World Effectiveness of Sotrovimab for the Early Treatment of COVID-19: Evidence from the US National COVID Cohort Collaborative (N3C). Clinical drug investigation 44 (3) (2024)
Vishal Patel, Bethany Levick, Stephen Boult, Daniel C Gibbons, Myriam Drysdale, Emily J Lloyd, Moushmi Singh, Helen J Birch
Characteristics and outcomes of COVID-19 patients presumed to be treated with sotrovimab in NHS hospitals in England. BMC infectious diseases 24 (1) (2024)
Christopher F Bell, Priyanka Jain, Raj Desai, Daniel C Gibbons, Myriam Drysdale, Maral DerSarkissian, Vishal Patel, Helen J Birch, Emily J Lloyd, Adina Zhang, Mei Sheng Duh, null null
Real-World Effectiveness of Sotrovimab for the Early Treatment of COVID-19: Evidence from the US National COVID Cohort Collaborative (N3C). Clinical drug investigation 44 (3) (2024)
Vishal Patel, Marcus J Yarwood, Bethany Levick, Daniel C Gibbons, Myriam Drysdale, William Kerr, Jonathan D Watkins, Sophie Young, Benjamin F Pierce, Emily J Lloyd, Helen J Birch, Tahereh Kamalati, Stephen James Brett
Characteristics and outcomes of patients with COVID-19 at high risk of disease progression receiving sotrovimab, oral antivirals or no treatment in England: a retrospective cohort study. Current medical research and opinion 40 (8) (2024)
Vishal Patel, Bethany Levick, Stephen Boult, Daniel C Gibbons, Myriam Drysdale, Emily J Lloyd, Moushmi Singh, Helen J Birch
Characteristics and outcomes of COVID-19 patients presumed to be treated with sotrovimab in NHS hospitals in England. BMC infectious diseases 24 (1) (2024)
Myriam Drysdale, Holly Tibble, Vishal Patel, Daniel C Gibbons, Emily J Lloyd, William Kerr, Calum Macdonald, Helen J Birch, Aziz Sheikh
Characteristics and outcomes of patients with COVID-19 at high risk of disease progression receiving sotrovimab, oral antivirals, or no treatment: a retrospective cohort study. BMC infectious diseases 24 (1) (2024)
Vishal Patel, Marcus J Yarwood, Bethany Levick, Daniel C Gibbons, Myriam Drysdale, William Kerr, Jonathan D Watkins, Sophie Young, Benjamin F Pierce, Emily J Lloyd, Helen J Birch, Tahereh Kamalati, Stephen James Brett
Characteristics and outcomes of patients with COVID-19 at high risk of disease progression receiving sotrovimab, oral antivirals or no treatment in England: a retrospective cohort study. Current medical research and opinion (2024)
Vishal Patel, Bethany Levick, Stephen Boult, Daniel C Gibbons, Myriam Drysdale, Emily J Lloyd, Moushmi Singh, Helen J Birch
Characteristics and outcomes of COVID-19 patients presumed to be treated with sotrovimab in NHS hospitals in England. BMC infectious diseases 24 (1) (2024)
Myriam Drysdale, Thor Hautekiet, Moushmi Singh, Joris Hautekiet, Linda Ludikhuyze, Vishal Patel, Daniel C Gibbons, Dorothée De Roeck, Kirsten Colpaert, Emily J Lloyd, Eva Van Braeckel
Characteristics and outcomes of patients treated with sotrovimab to prevent progression to severe COVID-19 in Belgium. Acta clinica Belgica 79 (3) (2024)
Myriam Drysdale, Holly Tibble, Vishal Patel, Daniel C Gibbons, Emily J Lloyd, William Kerr, Calum Macdonald, Helen J Birch, Aziz Sheikh
Characteristics and outcomes of patients with COVID-19 at high risk of disease progression receiving sotrovimab, oral antivirals, or no treatment: a retrospective cohort study. BMC infectious diseases 24 (1) (2024)
Myriam Drysdale, Thor Hautekiet, Moushmi Singh, Joris Hautekiet, Linda Ludikhuyze, Vishal Patel, Daniel C Gibbons, Dorothée De Roeck, Kirsten Colpaert, Emily J Lloyd, Eva Van Braeckel
Characteristics and outcomes of patients treated with sotrovimab to prevent progression to severe COVID-19 in Belgium. Acta clinica Belgica 79 (3) (2024)
Myriam Drysdale, Mehmet Berktas, Daniel C Gibbons, Catherine Rolland, Louis Lavoie, Emily J Lloyd
Real-world effectiveness of sotrovimab for the treatment of SARS-CoV-2 infection during Omicron BA.2 and BA.5 subvariant predominance: a systematic literature review. Infection (2024)
Myriam Drysdale, Daniel C Gibbons, Moushmi Singh, Catherine Rolland, Louis Lavoie, Andrew Skingsley, Emily J Lloyd
Real-world effectiveness of sotrovimab for the treatment of SARS-CoV-2 infection during Omicron BA.2 subvariant predominance: a systematic literature review. Infection (2023)
Daniel C Gibbons, Bhumika Aggarwal, Jolyon Fairburn-Beech, David Hinds, Monica Fletcher, Sinthia Z Bosnic-Anticevich, David J Price
Treatment patterns among non-active users of maintenance asthma medication in the United Kingdom: a retrospective cohort study in the Clinical Practice Research Datalink. The Journal of asthma : official journal of the Association for the Care of Asthma 58 (6) (2020)

Daniel C Gibbons.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Daniel C Gibbons